Emerging Resistance in Chlamydia Requires Surveillance and Reassessment
نویسندگان
doi
10.18502/jmb.v13i4.20530چکیده
Background: Chlamydia trachomatis remains one of the most common sexually transmitted infections (STIs) globally, often asymptomatic but capable of causing serious reproductive complications if left untreated. While azithromycin and doxycycline have traditionally been highly effective first-line treatments, recent evidence suggests a growing concern over reduced antibiotic efficacy and potential resistance.